Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SABCS 2018 /
Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer

4th - 8th Dec 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.12.18
Views: 760

Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands

Prof Emiel Rutgers gives a press conference at SABCS 2018 about the results from the phase III AMAROS clinical trial, where either axillary radiotherapy and axillary lymph node dissection were found to have comparable 10-year recurrence and survival rates in patients with early-stage breast cancer.

Watch his interview with ecancer here.

Read more about this work here.
 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation